Literature DB >> 19121767

Indoxyl sulfate promotes proliferation of human aortic smooth muscle cells by inducing oxidative stress.

Gulinuer Muteliefu1, Atsushi Enomoto, Toshimitsu Niwa.   

Abstract

OBJECTIVES: Cardiovascular disease is a major cause of mortality in chronic kidney disease patients. We have recently demonstrated that indoxyl sulfate (IS), a uremic toxin, induced aortic calcification and aortic wall thickening in hypertensive rats. This study aimed to determine if IS promotes proliferation of human aortic smooth muscle cells (HASMCs) and if antioxidants inhibit the IS-induced cell proliferation.
METHODS: We examined the effect of IS at different concentration from 50 to 500 mumol/L on cell proliferation of HASMCs by using 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1) assay. Further, the effect of antioxidants such as vitamin E, vitamin C, and N-acetylcysteine on the IS-induced proliferation of HASMCs was determined.
RESULTS: IS significantly promoted the proliferation of HASMCs concentration-dependently. The antioxidants significantly inhibited the IS-induced proliferation of HASMCs.
CONCLUSION: IS promotes proliferation of HASMCs by inducing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19121767     DOI: 10.1053/j.jrn.2008.10.014

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  16 in total

1.  Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.

Authors:  Tal Kopel; James S Kaufman; Naomi Hamburg; John S Sampalis; Joseph A Vita; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 8.237

2.  The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Authors:  Jennifer C Schroeder; Brett C Dinatale; Iain A Murray; Colin A Flaveny; Qiang Liu; Elizabeth M Laurenzana; Jyh Ming Lin; Stephen C Strom; Curtis J Omiecinski; Shantu Amin; Gary H Perdew
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

Review 3.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

Review 4.  A review of the effect of diet on cardiovascular calcification.

Authors:  Rachel Nicoll; John McLaren Howard; Michael Y Henein
Journal:  Int J Mol Sci       Date:  2015-04-21       Impact factor: 5.923

Review 5.  Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.

Authors:  Shunsuke Ito; Masayuki Yoshida
Journal:  Toxins (Basel)       Date:  2014-02-20       Impact factor: 4.546

6.  Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells.

Authors:  Maimaiti Yisireyili; Shinichi Saito; Shaniya Abudureyimu; Yelixiati Adelibieke; Hwee-Yeong Ng; Fuyuhiko Nishijima; Kyosuke Takeshita; Toyoaki Murohara; Toshimitsu Niwa
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 7.  Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease.

Authors:  Szu-Chun Hung; Ko-Lin Kuo; Chih-Cheng Wu; Der-Cherng Tarng
Journal:  J Am Heart Assoc       Date:  2017-02-07       Impact factor: 5.501

Review 8.  The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.

Authors:  Marion Sallée; Laetitia Dou; Claire Cerini; Stéphane Poitevin; Philippe Brunet; Stéphane Burtey
Journal:  Toxins (Basel)       Date:  2014-03-04       Impact factor: 4.546

9.  Uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells.

Authors:  Hitoshi Uchiyama; Masayuki Tsujimoto; Tadakazu Shinmoto; Hitomi Ogino; Tomoko Oda; Takuya Yoshida; Taku Furukubo; Satoshi Izumi; Tomoyuki Yamakawa; Hidehisa Tachiki; Tetsuya Minegaki; Kohshi Nishiguchi
Journal:  Toxins (Basel)       Date:  2014-09-03       Impact factor: 4.546

10.  The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease.

Authors:  Li-Han Chin; Yu-Juei Hsu; Shih-Che Hsu; Yen-Hui Chen; Yung-Lung Chang; Shih-Ming Huang; Chien-Sung Tsai; Chih-Yuan Lin
Journal:  Oncotarget       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.